A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease

Conditions: Sickle Cell Disease Interventions: Drug: Etavopivat Sponsors: Forma Therapeutics, Inc.; Novo Nordisk A/S Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials